Adimab signed a multi-target discovery agreement with Celgene Corporation, pursuant to which, Adimab will use its proprietary discovery and optimization platform to generate fully human antibodies against multiple targets. Under the terms ...
Tags: Adimab, Drug Discovery
Software and scientific consulting services provider Certara has signed a research agreement with The Hamner Institutes for Health Sciences, to explore the scientific benefits of using its Simcyp Simulator to drive hepatic drug exposure ...
US- based St. Jude Medical has acquired Endosense, a Switzerland-based company for a purchase price of $170m (CHF159m) up-front plus the potential for up to $161m (CHF150m) in subsequent milestone payments. While the acquisition is ...
CoAlign Innovations, a US-based medical device company, has received the US Food and Drug Administration (FDA) approval for its AccuLIF XL lateral expandable interbody fusion devices. The new AccuLIF interbody system utilizes low-profile ...
Increasing demand for antimicrobials from end-user applications such as medical devices boosts the antimicrobial coatings market in Asia-Pacific. The need to minimize infection and in turn, the cost of treatment has spurred the use of ...
Bureau Veritas' Consumer Product Services division (BVCPS) acquired Sargam Laboratory Private Limited (SLPL) in Chennai, India in 2011. The Sargam Laboratory has now been completely integrated with Bureau Veritas Consumer Product Services ...
Tags: Light Industry, Daily Use
THINK: Travel-friendly formulas for a smooth summer. WHAT THEY ARE: All the essentials for a flawless summer getaway. When it comes to blazing hot beach daysand sweltering summer nights, you want to look and feel your most refreshed. ...
Tags: Light Industry, Daily Use
Integrated biopharmaceutical company ThromboGenics has obtained Health Canada approval for Jetrea (ocriplasmin) for the treatment of symptomatic vitreomacular adhesion (VMA). Launch of the drug in Canada will be conducted by Alcon, ...
The US Food and Drug Administration (FDA) has approved GlaxoSmithKline's Flulaval Quadrivalent (Influenza Virus Vaccine) for the active immunization of people three years of age and more to help prevent disease caused by seasonal influenza ...
Tags: Flulaval Quadrivalent
The US Patent and Trademark Office (USPTO) has granted an US patent to the InSite Vision’s DuraSite 2 next-generation enhanced drug delivery system, which will be valid up to 2029 for internal pipeline and partnering. Offering a ...
Tags: Drug Delivery System
Northwestern's Bluhm Cardiovascular Institute has recently enrolled first patient in ABSORB III, a clinical trial to compare the performance of Abbott's drug eluting Absorb Bioresorbable Vascular Scaffold (BVS) device with other traditional ...
Tags: Absorb device, Medicine
c has submitted 510(k) application to the U.S. Food and Drug Administration (FDA) for marketing clearance of its MicroCutter XCHANGE 30, a cutting and stapling device designed to be used in multiple open and minimally invasive surgical ...
Tags: Microcutter Device
InSite Vision has secured the new patent for its DuraSite 2 next-generation enhanced drug delivery system from the United States Patent and Trademark Office (USPTO). DuraSite 2's ability to significantly improve drug retention and ...
Tags: Insite Vision, Ophthalmic Drug
Women are seeking care for alcohol abuse an average of four to five years earlier than their male counterparts, according to a study. The study's results will be published in the January 2014 issue of Alcoholism: Clinical & Experimental ...
Tags: alcohol abuse
Reports from Xinhua News Agency said that China will launch a new round of investigation lasting for three months to attack bribery in pharmaceutical and medical treatment fields. The investigation will be led by the State Administration ...
Tags: Health, Medicine, Drug Makers